NRG GY007 A Phase I II Study of Ruxolitinib with Front Line Neoadjuvant and Post Surgical Therapy

August 23, 2018
https://clinicaltrials.gov/ct2/show/NCT02713386
Cancer - Gynecologic/ Ovarian
Principal Investigator: Rabbie K Hanna, MD
GYNECOLOGIC, CANCER, OVARIAN, FALLOPIAN, EPITHELIAL, PERITONEAL
In Progress